-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
CNBX Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q4 2013 to Q4 2024.
- CNBX Pharmaceuticals Inc. Depreciation for the quarter ending November 30, 2024 was $0.000, a 100% decline year-over-year.
- CNBX Pharmaceuticals Inc. annual Depreciation for 2024 was $72.3K, a 55.4% decline from 2023.
- CNBX Pharmaceuticals Inc. annual Depreciation for 2023 was $162K, a 18.4% decline from 2022.
- CNBX Pharmaceuticals Inc. annual Depreciation for 2022 was $199K, a 10.1% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)